Initiate a Phase 2 trial of onvansertib in metastatic pancreatic ductal adenocarcinoma
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 25 Feb 2021
- Due
- 30 Jun 2021
- Delivered
- June 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Initiation of the Phase 2 trial is expected in the first half of 2021.”
What we found
Evidence strength A What the grades mean
Later 10-Q filings state the first patient in the Phase 2 pancreatic trial was dosed in June 2021, within the first-half 2021 deadline.
-
A Cardiff Oncology, Inc. 10-Q filed 2021-08-05
“PDAC CRDF-001 is a Phase 2 Study of onvansertib in combination with nanoliposomal irinotecan and 5-FU for the second line treatment of patients with metastatic pancreatic ductal adenocarcinoma ("PDAC"). The first patient was dosed in June 2021.” ✓ confirmed on the page
-
A Cardiff Oncology, Inc. 10-Q filed 2021-11-04
“The first patient was dosed in June 2021.” ✓ confirmed on the page
Checked 26 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Initiate
- Deliverable
- Phase 2 trial of onvansertib in metastatic PDAC
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Cardiff Oncology, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-CRDF-024678 · Corrections policy